PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
SEONGNAM, South Korea, Feb. 6, 2026 /PRNewswire/ — PharmaResearch Co., Ltd. (CEO: Jihoon Sohn) today announced that the U.S. Food…
